These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

521 related articles for article (PubMed ID: 28482155)

  • 1. Targeting the Receptor for Advanced Glycation Endproducts (RAGE): A Medicinal Chemistry Perspective.
    Bongarzone S; Savickas V; Luzi F; Gee AD
    J Med Chem; 2017 Sep; 60(17):7213-7232. PubMed ID: 28482155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular Characteristics of RAGE and Advances in Small-Molecule Inhibitors.
    Kim HJ; Jeong MS; Jang SB
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34199060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Receptor for advanced glycation end-products: Biological significance and imaging applications.
    Dobrucki IT; Miskalis A; Nelappana M; Applegate C; Wozniak M; Czerwinski A; Kalinowski L; Dobrucki LW
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2024; 16(1):e1935. PubMed ID: 37926944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic potential of targeting the receptor for advanced glycation end products (RAGE) by small molecule inhibitors.
    Singh H; Agrawal DK
    Drug Dev Res; 2022 Sep; 83(6):1257-1269. PubMed ID: 35781678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of RAGE Axis Signaling: A Pharmacological Challenge.
    Rojas A; Morales M; Gonzalez I; Araya P
    Curr Drug Targets; 2019; 20(3):340-346. PubMed ID: 30124149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RAGE and its ligands: from pathogenesis to therapeutics.
    Jangde N; Ray R; Rai V
    Crit Rev Biochem Mol Biol; 2020 Dec; 55(6):555-575. PubMed ID: 32933340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A fragment-based approach to discovery of Receptor for Advanced Glycation End products inhibitors.
    Kozlyuk N; Gilston BA; Salay LE; Gogliotti RD; Christov PP; Kim K; Ovee M; Waterson AG; Chazin WJ
    Proteins; 2021 Nov; 89(11):1399-1412. PubMed ID: 34156100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Development of Maillard Reaction, and Advanced Glycation End Product (AGE)-Receptor for AGE (RAGE) Signaling Inhibitors as Novel Therapeutic Strategies for Patients with AGE-Related Diseases.
    Shen CY; Lu CH; Wu CH; Li KJ; Kuo YM; Hsieh SC; Yu CL
    Molecules; 2020 Nov; 25(23):. PubMed ID: 33261212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of Advanced Glycation Endproduct (AGE)-Receptor for Advanced Glycation Endproduct (RAGE) Axis in Cardiovascular Disease and Its Therapeutic Intervention.
    Yamagishi SI
    Circ J; 2019 Aug; 83(9):1822-1828. PubMed ID: 31366777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. All the "RAGE" in lung disease: The receptor for advanced glycation endproducts (RAGE) is a major mediator of pulmonary inflammatory responses.
    Oczypok EA; Perkins TN; Oury TD
    Paediatr Respir Rev; 2017 Jun; 23():40-49. PubMed ID: 28416135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of AGE-RAGE Signalling as a Modulator of Gut Permeability in Diabetes.
    Snelson M; Lucut E; Coughlan MT
    Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycation & the RAGE axis: targeting signal transduction through DIAPH1.
    Shekhtman A; Ramasamy R; Schmidt AM
    Expert Rev Proteomics; 2017 Feb; 14(2):147-156. PubMed ID: 27967251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Receptor for advanced glycation endproducts (RAGE) and the complications of diabetes.
    Stern DM; Yan SD; Yan SF; Schmidt AM
    Ageing Res Rev; 2002 Feb; 1(1):1-15. PubMed ID: 12039445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular disease: what's all the AGE/RAGE about?
    Barlovic DP; Thomas MC; Jandeleit-Dahm K
    Cardiovasc Hematol Disord Drug Targets; 2010 Mar; 10(1):7-15. PubMed ID: 20041839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The RAGE Axis: A Relevant Inflammatory Hub in Human Diseases.
    Rojas A; Lindner C; Schneider I; Gonzalez I; Uribarri J
    Biomolecules; 2024 Mar; 14(4):. PubMed ID: 38672429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular investigation of glycated insulin-induced insulin resistance via insulin signaling and AGE-RAGE axis.
    Walke PB; Bansode SB; More NP; Chaurasiya AH; Joshi RS; Kulkarni MJ
    Biochim Biophys Acta Mol Basis Dis; 2021 Feb; 1867(2):166029. PubMed ID: 33248275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Receptor for advanced glycation end products mediates sepsis-triggered amyloid-β accumulation, Tau phosphorylation, and cognitive impairment.
    Gasparotto J; Girardi CS; Somensi N; Ribeiro CT; Moreira JCF; Michels M; Sonai B; Rocha M; Steckert AV; Barichello T; Quevedo J; Dal-Pizzol F; Gelain DP
    J Biol Chem; 2018 Jan; 293(1):226-244. PubMed ID: 29127203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic Interventions for Advanced Glycation-End Products and its Receptor- Mediated Cardiovascular Disease.
    Prasad K; Tiwari S
    Curr Pharm Des; 2017; 23(6):937-943. PubMed ID: 27719648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of receptor for advanced glycation end products: a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis.
    Schmidt AM; Yan SD; Wautier JL; Stern D
    Circ Res; 1999 Mar; 84(5):489-97. PubMed ID: 10082470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cysteine mediated disulfide bond formation in RAGE V domain facilitates its functionally relevant dimerization.
    Jangde N; Ray R; Sinha S; Rana K; Singh SK; Khandagale P; Acharya N; Rai V
    Biochimie; 2018 Nov; 154():55-61. PubMed ID: 30076903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.